Athens Medical C.S.A.
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and … Read more
Athens Medical C.S.A. (IATR) - Net Assets
Latest net assets as of June 2025: €110.03 Million EUR
Based on the latest financial reports, Athens Medical C.S.A. (IATR) has net assets worth €110.03 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€526.18 Million) and total liabilities (€416.15 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €110.03 Million |
| % of Total Assets | 20.91% |
| Annual Growth Rate | 3.96% |
| 5-Year Change | 24.98% |
| 10-Year Change | 84.9% |
| Growth Volatility | 9.77 |
Athens Medical C.S.A. - Net Assets Trend (2014–2024)
This chart illustrates how Athens Medical C.S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Athens Medical C.S.A. (2014–2024)
The table below shows the annual net assets of Athens Medical C.S.A. from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €108.81 Million | +0.04% |
| 2023-12-31 | €108.77 Million | +5.34% |
| 2022-12-31 | €103.25 Million | +1.17% |
| 2021-12-31 | €102.06 Million | +17.22% |
| 2020-12-31 | €87.07 Million | +10.09% |
| 2019-12-31 | €79.08 Million | +10.42% |
| 2018-12-31 | €71.62 Million | +13.36% |
| 2017-12-31 | €63.18 Million | +4.17% |
| 2016-12-31 | €60.65 Million | +3.07% |
| 2015-12-31 | €58.85 Million | -20.27% |
| 2014-12-31 | €73.81 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Athens Medical C.S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 92.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €51.70 Million | 47.60% |
| Other Components | €56.90 Million | 52.40% |
| Total Equity | €108.61 Million | 100.00% |
Athens Medical C.S.A. Competitors by Market Cap
The table below lists competitors of Athens Medical C.S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CLS HLDGS PLC LS-025
F:838
|
$85.79 Million |
|
GENOVIS AB SE-40
F:5GV
|
$85.82 Million |
|
All For One Steeb AG
F:A1OS
|
$85.87 Million |
|
Danang Rubber JSC
VN:DRC
|
$85.87 Million |
|
EXCO TECHS LTD
F:3XT
|
$85.78 Million |
|
ENB Financial Corp
OTCQX:ENBP
|
$85.76 Million |
|
Optimax Technology Corp
TW:3051
|
$85.75 Million |
|
PDS Limited
NSE:PDSL
|
$85.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Athens Medical C.S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 108,665,000 to 108,605,000, a change of -60,000 (-0.1%).
- Net income of 1,779,000 contributed positively to equity growth.
- Dividend payments of 1,728,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €1.78 Million | +1.64% |
| Dividends Paid | €1.73 Million | -1.59% |
| Other Changes | €-111.00K | -0.1% |
| Total Change | €- | -0.06% |
Book Value vs Market Value Analysis
This analysis compares Athens Medical C.S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.31x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.99x to 1.31x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €0.83 | €1.64 | x |
| 2019-12-31 | €0.91 | €1.64 | x |
| 2020-12-31 | €1.00 | €1.64 | x |
| 2021-12-31 | €1.18 | €1.64 | x |
| 2022-12-31 | €1.19 | €1.64 | x |
| 2023-12-31 | €1.25 | €1.64 | x |
| 2024-12-31 | €1.25 | €1.64 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Athens Medical C.S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.64%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.66%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 4.57x
- Recent ROE (1.64%) is above the historical average (1.58%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -25.23% | -12.47% | 0.39x | 5.18x | €-25.92 Million |
| 2015 | -26.85% | -9.98% | 0.43x | 6.30x | €-21.65 Million |
| 2016 | 5.72% | 2.07% | 0.45x | 6.08x | €-2.60 Million |
| 2017 | 4.16% | 1.55% | 0.47x | 5.72x | €-3.69 Million |
| 2018 | 15.03% | 5.89% | 0.51x | 5.02x | €3.60 Million |
| 2019 | 9.59% | 3.85% | 0.54x | 4.65x | €-320.50K |
| 2020 | 4.51% | 2.09% | 0.45x | 4.81x | €-4.78 Million |
| 2021 | 14.75% | 6.66% | 0.53x | 4.14x | €4.84 Million |
| 2022 | 6.63% | 2.93% | 0.56x | 4.05x | €-3.48 Million |
| 2023 | 7.44% | 3.13% | 0.54x | 4.39x | €-2.78 Million |
| 2024 | 1.64% | 0.66% | 0.54x | 4.57x | €-9.08 Million |
Industry Comparison
This section compares Athens Medical C.S.A.'s net assets metrics with peer companies in the Medical Care Facilities industry.
No peer company data available for comparison.